Beijing Kawin Technology Share-holding Co Ltd - Asset Resilience Ratio
Beijing Kawin Technology Share-holding Co Ltd (688687) has an Asset Resilience Ratio of 12.53% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Beijing Kawin Technology Share-holding Co Ltd's Asset Resilience Ratio has changed over time. See how financially flexible is Beijing Kawin Technology Share-holding C to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Beijing Kawin Technology Share-holding Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Beijing Kawin Technology Share-holding C.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥337.92 Million | 12.53% |
| Total Liquid Assets | CN¥337.92 Million | 12.53% |
Asset Resilience Insights
- Moderate Liquidity: Beijing Kawin Technology Share-holding Co Ltd has 12.53% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Beijing Kawin Technology Share-holding Co Ltd Industry Peers by Asset Resilience Ratio
Compare Beijing Kawin Technology Share-holding Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND |
Biotechnology | 0.00% |
|
Halozyme Therapeutics Inc
NASDAQ:HALO |
Biotechnology | 12.71% |
|
Akero Therapeutics Inc
NASDAQ:AKRO |
Biotechnology | 55.87% |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
Biotechnology | 8.08% |
|
Zealand Pharma A/S
CO:ZEAL |
Biotechnology | 63.98% |
|
Verona Pharma PLC ADR
NASDAQ:VRNA |
Biotechnology | 0.00% |
|
Immunitybio Inc
NASDAQ:IBRX |
Biotechnology | 38.07% |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
Biotechnology | 37.31% |
Annual Asset Resilience Ratio for Beijing Kawin Technology Share-holding Co Ltd (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Beijing Kawin Technology Share-holding Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 10.29% | CN¥287.50 Million ≈ $42.07 Million |
CN¥2.79 Billion ≈ $408.72 Million |
-3.12pp |
| 2024-12-31 | 13.41% | CN¥350.87 Million ≈ $51.34 Million |
CN¥2.62 Billion ≈ $382.75 Million |
-1.51pp |
| 2023-12-31 | 14.92% | CN¥365.33 Million ≈ $53.46 Million |
CN¥2.45 Billion ≈ $358.25 Million |
-8.21pp |
| 2022-12-31 | 23.13% | CN¥511.12 Million ≈ $74.79 Million |
CN¥2.21 Billion ≈ $323.35 Million |
+19.46pp |
| 2021-12-31 | 3.67% | CN¥80.00 Million ≈ $11.71 Million |
CN¥2.18 Billion ≈ $318.67 Million |
-- |
About Beijing Kawin Technology Share-holding Co Ltd
Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China and internationally. The company offers recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon alfacon-2 injection; and compound glycyrrhiz… Read more